High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration

American Heart Journal

Volumn 161, Issue 3, 2011, Pages

  De Boer, Sanneke P M ^a   Barnes, Elizabeth H ^b   Westerhout, Cynthia M ^c   Simes, R John ^b   Granger, Christopher B ^d   Kastrati, Adnan ^e   Widimsky, Petr ^f   De Boer, Menko Jan ^g   Zijlstra, Felix ^a   Boersma, Eric ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b National Health and Medical Research Council Clinical Trials Centre   (Australia)

^c UNIVERSITY OF ALBERTA   (Canada)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f CHARLES UNIVERSITY   (Czech Republic)

^g ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOT LYSIS; CALIBRATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; HEART RATE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 79952431948     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.11.022     Document Type: Article

References (16)

1. Van de Werf F., Bax J., and Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 23 2008 2909 2945
2. Antman E.M., Anbe D.T., and Armstrong P.W. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) Circulation 110 2004 588 636 (Pubitemid 39036178)
3. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
4. Boersma E. for the PCAT-2 investigators Does time matter? A pooled analysis of randomised clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients Eur Heart J 27 2006 779 788
5. De Boer S., Westerhout CM, Simes RJ for the PCAT-2 investigators Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age JACC Catheter Cardiovasc 2010 [in press]
6. Henriques J.P., Haasdijk A.P., Zijlstra F. on behalf of the Zwolle Myocardial Infarction Study group Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours JACC 41 2003 2138 2142 (Pubitemid 36724258)
7. Harrell F.E. Jr, Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
8. Grines C., Patel A., and Zijlstra F. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomised trials Am Heart J 145 2003 47 57 (Pubitemid 36034497)
9. Lee K.L., Woodlief L.H., and Topol E.J. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 1995 1659 1668
10. Morrow D.A., Antman E.M., and Charlesworth A. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
11. Granger C.B., Goldberg R.J., Dabbous O.H. for the Global Registry of Acute Coronary Events Investigators Predictors of hospital mortality in the Global Registry of Acute Coronary Events Arch Int Med 163 2003 2345 2353 (Pubitemid 37310196)
12. Eagle K.A., Lim M.J., Dabbous O.H. for the GRACE Investigators A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post discharge death in an international registry JAMA 291 2004 2727 2733 (Pubitemid 38725422)
13. Buller C.E., Fu Y., and Mahaffey K.W. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction Circulation 118 2008 1335 1346
14. Al Suwaidi J., Reddan D.N., and Williams K. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes Circulation 106 2002 974 980 (Pubitemid 34925333)
15. Fibrinolytic Therapy Trialists' (FTT) Collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 1994 311 322
16. Boersma E., Maas A.C., and Deckers J.W. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Lancet 348 1996 771 775 (Pubitemid 26308479)